New combo therapy aims to boost prostate cancer fight before surgery
NCT ID NCT07182279
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a high dose of internal radiation (brachytherapy) before robotic prostate surgery can safely improve outcomes for men with high-risk prostate cancer. About 29 participants will receive the radiation, then surgery, and possibly short-term hormone therapy if needed. The goal is to see if this approach is safe and helps control the disease better than surgery alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK PROSTATE ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Houston Methodist
RECRUITINGHouston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a new drug combo tame resistant prostate cancer?
- Virtual cooking classes aim to boost health for hispanic prostate cancer survivors and their families
- Prostate Surgery's hidden toll: study probes lasting impact on Men's lives
- Which gas pump causes less pain during robotic prostate surgery? a Head-to-Head trial
- Nerve-Sparing radiation may help men keep sexual function after prostate cancer treatment